Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study.
6 affiliations
- 1Department of Clinical and Molecular Medicine, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, P.O. 8905, Trondheim, Trøndelag, 7491, Norway, 47 72853114.
- 2Cancer Clinic, St Olav's University Hospital, Trondheim, Trøndelag, Norway.
- 3Unicare, Oslo, Norway.
- 4Department of Oncology, Division of Cancer Medicine, Oslo University Hospital, Oslo, Norway.
- 5Department of Health Services Research, SINTEF Digital, Trondheim, Trøndelag, Norway.
- 6Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Trondheim, Trøndelag, Norway.
Abstract
Background
Due to advances in cancer diagnostics and treatments, life expectancy after cancer and the number of cancer survivors are increasing. Symptoms and late effects frequently occur in cancer survivors, with a negative impact on functioning and participation in society. Digital health tools might be helpful to systematically assess symptom burden of late effects and rehabilitation needs.Objective
This paper describes the objectives, design, and current status of the Cancer Rehabilitation Screening (CaReScreen) project. The aims are (1) to report the completed development phase of the digital health tool CaReScreen, comprising the exploratory work, the establishment of the interdisciplinary team, the selection of the assessment instrument, and the development of the initial prototype, and (2) to define the objectives, design, and timelines of the ongoing validation of the scoring manual and of the planned large-scale feasibility study.Methods
Development followed an iterative, qualitative, and participatory design approach guided by established frameworks for digital health development. It was informed by exploratory qualitative work comprising 40 interviews (9 group and 31 individual) involving 72 informants across Norway, which identified systematic assessment of late effects and navigation of rehabilitation services as the primary unmet needs in cancer survivorship follow-up. A 105-item patient-reported outcome measure (European Organization for Research and Treatment of Cancer [EORTC] QLQ-SURV100, supplemented with 5 EORTC QLQ-C30 items) was selected as the main assessment instrument. This paper reports the completed development phase; the ongoing validation study and the planned feasibility study are described in terms of objectives, design, and timelines, but their results are not reported here.Results
An initial prototype was developed with health care professionals and cancer survivors as intended end users. It consists of a digital report that identifies and graphically visualizes a panoramic view of multidimensional needs, based on a traffic light scoring system: green indicates low symptom burden and high functioning, yellow moderate symptom burden and moderate functioning, and red high symptom burden and low functioning. The project is funded for the period 2022 to 2028. The development phase is completed, as well as early prototype usability and usefulness testing. Validation of the scoring manual is ongoing, with 800 participants included to date and reporting expected in spring 2027. A large-scale feasibility study is planned to commence in 2027.Conclusions
The CaReScreen interdisciplinary team has developed an initial digital health tool prototype with the main aim of enabling systematic assessment of late effects, functioning, and unmet rehabilitation needs in cancer survivors. The prototype now proceeds to validation and feasibility testing, which will determine its clinical utility and support regulatory approval under the European Medical Device Regulation.
Related
- A decade of implementing comprehensive child development services in Northwest Iran: a qualitative study of provider perspectives on barriers and facilitators
- Co-production using Theory of Change in the development of the SUCCEED Africa community-based rehabilitation intervention for people living with psychosis in West and Southeast Africa
- Development and Psychometric Validation of a Multidimensional Questionnaire for Assessing Interpersonal Social Health
- Development of a psychosocial intervention in cardiac rehabilitation: a co-creation process
- Synaptopodin KO rat for assessing the dendritic spine apparatus and axonal cisternal organelle in synaptic plasticity, development, and behavior
BibTeX
@article{kulosman2026development,
title = {{Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study.}},
author = {Maja Kulosman and Harald Kåre Engan and Unn Merete Fagerli and Kristin Valborg Reinertsen and Kari Sand and Jon Arne Sandmæl and Arne Solberg and Torgrim Tandstad},
journal = {JMIR research protocols},
year = {2026},
month = oct,
doi = {10.2196/105443},
url = {https://europepmc.org/article/MED/42956043},
note = {CC BY},
}
RIS
TY - JOUR
TI - Development of CaReScreen, a Digital Health Tool for Assessing Late Effects and Cancer Rehabilitation Needs in Cancer Survivors: Protocol for a Qualitative Development and Formative Design Study.
AU - Maja Kulosman
AU - Harald Kåre Engan
AU - Unn Merete Fagerli
AU - Kristin Valborg Reinertsen
AU - Kari Sand
AU - Jon Arne Sandmæl
AU - Arne Solberg
AU - Torgrim Tandstad
PY - 2026
DA - 2026/10/29
JO - JMIR research protocols
DO - 10.2196/105443
UR - https://europepmc.org/article/MED/42956043
AB - Background Due to advances in cancer diagnostics and treatments, life expectancy after cancer and the number of cancer survivors are increasing. Symptoms and late effects frequently occur in cancer survivors, with a negative impact on functioning and participation in society. Digital health tools might be helpful to systematically assess symptom burden of late effects and rehabilitation needs.Objective This paper describes the objectives, design, and current status of the Cancer Rehabilitation Screening (CaReScreen) project. The aims are (1) to report the completed development phase of the digital health tool CaReScreen, comprising the exploratory work, the establishment of the interdisciplinary team, the selection of the assessment instrument, and the development of the initial prototype, and (2) to define the objectives, design, and timelines of the ongoing validation of the scoring manual and of the planned large-scale feasibility study.Methods Development followed an iterative, qualitative, and participatory design approach guided by established frameworks for digital health development. It was informed by exploratory qualitative work comprising 40 interviews (9 group and 31 individual) involving 72 informants across Norway, which identified systematic assessment of late effects and navigation of rehabilitation services as the primary unmet needs in cancer survivorship follow-up. A 105-item patient-reported outcome measure (European Organization for Research and Treatment of Cancer [EORTC] QLQ-SURV100, supplemented with 5 EORTC QLQ-C30 items) was selected as the main assessment instrument. This paper reports the completed development phase; the ongoing validation study and the planned feasibility study are described in terms of objectives, design, and timelines, but their results are not reported here.Results An initial prototype was developed with health care professionals and cancer survivors as intended end users. It consists of a digital report that identifies and graphically visualizes a panoramic view of multidimensional needs, based on a traffic light scoring system: green indicates low symptom burden and high functioning, yellow moderate symptom burden and moderate functioning, and red high symptom burden and low functioning. The project is funded for the period 2022 to 2028. The development phase is completed, as well as early prototype usability and usefulness testing. Validation of the scoring manual is ongoing, with 800 participants included to date and reporting expected in spring 2027. A large-scale feasibility study is planned to commence in 2027.Conclusions The CaReScreen interdisciplinary team has developed an initial digital health tool prototype with the main aim of enabling systematic assessment of late effects, functioning, and unmet rehabilitation needs in cancer survivors. The prototype now proceeds to validation and feasibility testing, which will determine its clinical utility and support regulatory approval under the European Medical Device Regulation.
SN - 1929-0748
ER -